10 Stocks With At Least $20 Million In Insider Spending Recently

7. Sionna Therapeutics, Inc. (NASDAQ:SION)

Highest Individual Purchase: $20,250,000.00

Number of Purchases Worth Between $20 million and $35 million: 1

Market Capitalization: $611 million

Sionna Therapeutics is a cystic fibrosis (CF) focused biopharmaceutical company. The Boston, Massachusetts-based company is working on new treatments that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. Its goal is to create various medicines for people with CF that will restore CFTR function to nearly normal.

The company’s co-founders bring over a decade of research experience in this field, and Sionna is focused on developing a pipeline of small molecules designed to address the defects caused by the most prevalent CF genetic mutation.

Since this is a new stock on the market, analyst coverage is very limited, and there are no public finance reports available yet.

Sionna is also among 10 stocks insiders are buying this year.